Trials / Completed
CompletedNCT02973776
Vasoconstriction Trial With LEO 90100 Aerosol Foam
Vasoconstriction Trial Comparing LEO 90100 With Dermovate Cream, Diprosone Ointment, Elocon Cream, Locoid Ointment and LEO 90100 Vehicle
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Vasoconstriction study with LEO 90100
Detailed description
This study compares the pharmacodynamic activity of LEO 90100 with Dermovate cream, Diprosone ointment, Elocon cream, Locoid ointment and LEO 90100 vehicle using a human skin blanching test
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LEO 90100 aerosol foam | |
| DRUG | Dermoval®/Dermovate® | |
| DRUG | Diprosone | |
| DRUG | Elocon | |
| DRUG | Locoid | |
| OTHER | LEO 90100 foam vehicle |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2016-11-25
- Last updated
- 2017-05-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02973776. Inclusion in this directory is not an endorsement.